NIH-funded research R01 grant

Understanding how lipotoxicity affects metabolic health and diabetes complications

Official title: Lipotoxicity and Maintenance of Metabolic Health

Funded at Joslin Diabetes Center · NIH-11085238 · Data updated 2026-11-12

This study is looking at how tiny molecules called snoRNAs might help protect against damage from fatty foods, which can lead to problems like fatty liver disease in people with type 2 diabetes, using mice to see what happens when these snoRNAs are missing.

More Metabolic Health research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2023
Project endApril 30, 2027
Funding year2025
Award (this year)$594,765
NIH project number5R01DK137511-03
Project IDNIH-11085238 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who are experiencing complications related to type 2 diabetes or metabolic disorders.

Less likely to help

Patients who do not have type 2 diabetes or related metabolic conditions may not benefit from this research.

What this research studies

This research investigates the role of small nucleolar RNAs (snoRNAs) in protecting against lipotoxicity, which is a significant factor in complications related to type 2 diabetes, such as non-alcoholic fatty liver disease (NAFLD). By using a mouse model, the study aims to explore how the absence of specific snoRNAs can prevent tissue damage caused by high-fat diets. The research will also examine the connections between snoRNA levels, mRNA translation, and dietary influences, potentially leading to new treatment strategies for metabolic diseases.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic targets for treating metabolic diseases and improving health outcomes for patients with diabetes.

How similar studies have gone: Previous research has shown promising results in understanding the role of snoRNAs in cellular processes, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Schaffer, Jean E. — Joslin Diabetes Center
  • Study coordinator: Schaffer, Jean E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.